Blood and brain injury biomarker study for inherited metabolic disorders
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an inherited disorder that causes high ammonia (urea cycle disorders like OTCD, CPSD, or NAGS)
- OR you have an inherited organic acidemia (like propionic acidemia or methylmalonic acidemia)
- OR you have had certain metabolic emergencies (like MSUD or glutaric acidemia) with or without brain effects
- OR you had hypoxic-ischemic encephalopathy (brain injury from lack of oxygen/blood flow)
- You have not had a solid-organ transplant
- You are not using other experimental treatments that would interfere with measuring the study biomarkers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at liver tissue (under a microscope) in people with urea cycle disorders to better understand liver changes from the condition. It may help clinicians learn what to watch for and how to manage liver health, especially around liver biopsy or transplant.
This trial tests a device for measuring ammonia levels at home in people with rare metabolic conditions that cause high ammonia. It aims to make monitoring easier and more convenient for patients.
This study evaluates how people with urea cycle disorders perform during a driving task. It may help researchers understand if the condition affects driving ability.
This study uses MRI scans and memory/thinking tests to understand brain effects of urea cycle disorders, like ornithine transcarbamylase deficiency (OTCD) and argininosuccinate (ASSD/ASLD). It may help researchers understand how brain function changes during and between metabolic crises.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
This trial tests a new medicine called LNP.UCD.ABE that aims to fix a specific genetic change causing a severe urea cycle disorder. It uses a technique called base editing to correct the gene mutation, which may help your body break down ammonia better.
Hear when a new Organic Acidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.